These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 29437872)

  • 1. Mathematical and Experimental Validation of Flux Dialysis Method: An Improved Approach to Measure Unbound Fraction for Compounds with High Protein Binding and Other Challenging Properties.
    Kalvass JC; Phipps C; Jenkins GJ; Stuart P; Zhang X; Heinle L; Nijsen MJMA; Fischer V
    Drug Metab Dispos; 2018 Apr; 46(4):458-469. PubMed ID: 29437872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct determination of the ratio of unbound fraction in plasma to unbound fraction in microsomal system (fu p/fu mic) for refined prediction of phase I mediated metabolic hepatic clearance.
    Deshmukh SV; Harsch A
    J Pharmacol Toxicol Methods; 2011; 63(1):35-9. PubMed ID: 20433934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using Counter Equilibrium Dialysis (CED) to Increase Confidence in the Measurement of Free Fraction for Challenging Compounds.
    Huang J; Yan Z; Cai J
    J Pharm Sci; 2023 Sep; 112(9):2561-2569. PubMed ID: 37187260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma Protein Binding of Challenging Compounds.
    Riccardi K; Cawley S; Yates PD; Chang C; Funk C; Niosi M; Lin J; Di L
    J Pharm Sci; 2015 Aug; 104(8):2627-36. PubMed ID: 26037784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improving Confidence in the Determination of Free Fraction for Highly Bound Drugs Using Bidirectional Equilibrium Dialysis.
    Chen YC; Kenny JR; Wright M; Hop CECA; Yan Z
    J Pharm Sci; 2019 Mar; 108(3):1296-1302. PubMed ID: 30326208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of the Time to Reach Equilibrium for Improved Estimation of the Unbound Fraction of Compounds in Equilibrium Dialysis Using kinetic Modeling.
    Bae C; Chung G; Chung SJ
    J Pharm Sci; 2023 Nov; 112(11):2901-2909. PubMed ID: 37392902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies of drug binding to plasma proteins using a variant of equilibrium dialysis.
    Eriksson MA; Gabrielsson J; Nilsson LB
    J Pharm Biomed Anal; 2005 Jul; 38(3):381-9. PubMed ID: 15925237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving the accuracy of unbound fraction measurement of drug-protein binding by preconditioning the RED membrane inserts.
    Ye Z; Chen Q
    Bioanalysis; 2020 Dec; 12(23):1699-1708. PubMed ID: 33179537
    [No Abstract]   [Full Text] [Related]  

  • 9. Impact of pH on plasma protein binding in equilibrium dialysis.
    Kochansky CJ; McMasters DR; Lu P; Koeplinger KA; Kerr HH; Shou M; Korzekwa KR
    Mol Pharm; 2008; 5(3):438-48. PubMed ID: 18345638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Approaches to measure protein binding of enzymatically unstable compounds in plasma.
    Ye Z; Gao H
    Bioanalysis; 2018 Apr; 10(7):451-459. PubMed ID: 29633861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Applying Two Orthogonal Methods to Assess Accuracy of Plasma Protein Binding Measurements for Highly Bound Compounds.
    Ryu S; Riccardi K; Patel R; Zueva L; Burchett W; Di L
    J Pharm Sci; 2019 Nov; 108(11):3745-3749. PubMed ID: 31419399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interethnic scaling of fraction unbound of a drug in plasma and volume of distribution: an analysis of extrapolation from Caucasians to Chinese.
    Yu G; Zhou HH; Zheng QS; Li GF
    Eur J Clin Pharmacol; 2019 Apr; 75(4):543-551. PubMed ID: 30569284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implications of plasma protein binding for pharmacokinetics and pharmacodynamics of the γ-secretase inhibitor RO4929097.
    Wu J; Lorusso PM; Matherly LH; Li J
    Clin Cancer Res; 2012 Apr; 18(7):2066-79. PubMed ID: 22351688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pH dependency of the binding of drugs to plasma proteins in man.
    Hinderling PH; Hartmann D
    Ther Drug Monit; 2005 Feb; 27(1):71-85. PubMed ID: 15665750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of a Competitive Equilibrium Dialysis Approach for Assessing the Impact of Protein Binding on Clearance Predictions.
    Jones RS; Chang JH; Flores M; Brecht E
    J Pharm Sci; 2021 Jan; 110(1):536-542. PubMed ID: 32941852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of unbound fraction of pazopanib in vitro and in cancer patients reveals albumin as the main binding site.
    Imbs DC; Paludetto MN; Négrier S; Powell H; Lafont T; White-Koning M; Chatelut E; Thomas F
    Invest New Drugs; 2016 Feb; 34(1):41-8. PubMed ID: 26572909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Equilibrium gel filtration to measure plasma protein binding of very highly bound drugs.
    Weiss HM; Gatlik E
    J Pharm Sci; 2014 Feb; 103(2):752-9. PubMed ID: 24375113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of dolutegravir's unbound fraction in human plasma using validated equilibrium dialysis and LC-MS/MS methods.
    Metsu D; Lanot T; Fraissinet F; Picot M; Concordet D; Cabrol M; Dubois-Galopin F; Chatelut E; Delobel P; Gandia P
    Clin Chim Acta; 2018 Apr; 479():56-65. PubMed ID: 29277535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strategy for Determining the Free Fraction of Labile Covalent Modulators in Plasma Using Equilibrium Dialysis.
    Leung C; Kenny JR; Hop CECA; Yan Z
    J Pharm Sci; 2020 Oct; 109(10):3181-3189. PubMed ID: 32663597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Addressing the Accuracy of Plasma Protein Binding Measurement for Highly Bound Compounds Using the Dilution Method.
    Ryu S; Tess D; Di L
    AAPS J; 2022 Dec; 25(1):7. PubMed ID: 36471200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.